patient access News
-
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the launch of its Patient Therapy Access Program (“PTAP”), which will provide qualifying patients access to on-label Portable Neuromodulation Stimulator (“PoNS”) Therapy at a significantly reduced price. ...
-
A Latvian start-up recognised in European healthcare accelerator programme
In the Headstart Programme, EIT Health decided to support 89 healthcare start-ups in Europe, including 17 teams from more progressing regions. Seven start-ups come from Italy, two from Portugal, Poland, and Estonia and one from Greece, Romania, Hungary, and Latvia. All the teams get €40 000 to develop their innovations and entice private investment. Start-ups will compete for an additional ...
By Longenesis
-
Leanness and the culture of improvement - healthcare management forum
TOPIC: Leanness and the Culture of Improvement Plenary Session 2 at Healthcare Management Forum: Process Improvement and Operational Excellence WHEN: Monday, April 4 2011 at 10:00 a.m WHERE: Toronto Priority Code: 3BL1 Featuring: Matthew Anderson, President and Chief Executive Officer, William Osler Health System Robert S. Bell, President and Chief Executive Officer, University Health Network ...
By 3BL Media
-
Isabel Healthcare partners with Riverwood Healthcare to offer online symptom checker
Isabel Healthcare and Riverwood Healthcare have partnered to integrate Isabel’s AI symptom checker / self-triage platform into the Riverwood website to enhance care access and patient engagement. The symptom checker has been customized for Riverwood with integration of live chat and care option selection links and other pertinent content to help patients navigate to Riverwood care services ...
-
Chiesi Group and Holostem Terapie Avanzate announce transfer of Holoclar® from the Chiesi Group to Holostem
Parma and Modena, 16 June 2020 – Chiesi Farmaceutici, international research-focussed group (Chiesi Group), and Holostem Terapie Avanzate, top Italian biotech company entirely dedicated to the development, production, registration and distribution of medicinal products for advanced therapies, announce the signing of a contract for the transfer of the business branch of Holoclar®, an ...
-
Melbourne innovation set to revolutionize cell therapy industry
A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and ...
-
The Centers for Medicare and Medicaid (CMS) announced the MCIT pathway to provide national Medicare coverage for FDA Breakthrough Devices and Diagnostic
The Centers for Medicaid and Medicare (CMS) announced the establishment of the MCIT (Medicare Coverage of Innovative Technology) pathway, which is designed to provide coverage and access to new, innovative medical devices and diagnostics which have received FDA Breakthrough Device Designation to Medicare beneficiaries nationwide. Through this pathway, Breakthrough devices will automatically be ...
-
BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies working to eradicate COVID-19 and lead to less patient access to lifesaving treatments. Dr. McMurry-Heath raised these and other ...
-
Simeox device is now available in Canada!
We are happy to announce that the #simeox device is now commercially available in Canada. Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, ...
By PhysioAssist
-
Mercury Biomed Awarded Key New Patent
Mercury Biomed announces that the United States Patent and Trademark Office (USPTO), after substantive examination, has issued its patent application entitled, “Altering Temperature in a Mammalian Body ” (U.S. Patent No. 9,549,844). The 844 patent, having a September 2009 priority date and exclusively licensed from the University of Texas at Austin, further expands Mercury’s ...
-
Biocon Biologics Partner Viatris Wins U.S. Court Decisions on Sanofi Appeals for Lantus Device Patents
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Court of Appeals for the Federal Circuit (USCAFC) has upheld the U.S. Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus® SoloSTAR®, as well as a district court decision on one of these patents. The Patent ...
By Biocon
-
Signifier Medical Technologies is granted HCPCS Codes for eXciteOSA to help patients access innovative technology
Signifier Medical Technologies LLC, a Boston-based medical technology company, announced today that the Centers for Medicare & Medicaid Services (CMS) established two new Level II Healthcare Common Procedure Coding System (HCPCS) codes to describe eXciteOSA, the first-ever FDA authorized de-novo device for daytime treatment of mild obstructive sleep apnea (OSA) and primary snoring. The CMS ...
-
CrossBay Medical’s Newly Launched Website Demonstrates Patient-Friendly CrossGlide Technology Platform
CrossBay Medical, Inc., a health technology company focused on humanizing the delivery of women’s healthcare, has announced the launch of a new website, introducing its CrossGlide™ technology platform. The site, www.crossbaymedicalinc.com features animation and videos unveiling the CrossGlide concept and how it works to enhance and improve the patient experience for cervical access ...
-
LifeScan’s Response to the Invasion of Ukraine
For over 40 years, LifeScan’s vision has been to create a world without limits for people with diabetes and related conditions, and this remains as strong today as ever, and perhaps when our support is needed most. Therefore, we are responding to the urgent humanitarian need for diabetes health medical supplies resulting from the invasion of Ukraine. As part of our longstanding commitment ...
By LifeScan
-
Versius adopted by Cristo Re Hospital to increase patient access to keyhole surgery in Rome
CMR Surgical – the global medical device company headquartered in Cambridge, UK – has announced the installation of its first Versius system in Rome, at the Cristo Re Hospital. Cristo Re is part of the renowned GIOMI Group and is the first of the leading group of private clinics in Italy to install this practical and innovative surgical tool. Versius is being used as part of a ...
-
Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost
On July 15, 2021, The openning ceremony of a new state of the art peptide manufacture facility was held in Jintang, Chengdu. The successful completion of the facility marks the successful industrialization of Aikening® in Jintang. Aiming at intelligent manufacturing, high efficiency and eco system, and a quality system to be certified by the US FDA, EU EMA and China NMPA, the peptide ...
-
Welcome T2
A complete redesign of the T-Stat was launched in 2020. New features included a sleek and strong exterior of powder coated metal, framed with a soft plastic bumper to prevent any damage in the hospital environment. Battery back-up was added to make patient ambulation and transfer seemless and without any interruption in patient data. WiFi access has been added to accommodate hospitals and labs ...
-
$30 Million Series B Financing and Expansion of Scientific Advisory Board
Ablacon, Inc., an Ajax Health-backed company, announced the close of a $30 million Series B financing, with Zeus Health joining as new lead investor. Ablacon also announced the addition of Dr. David Haines, Professor of Cardiovascular Medicine at Oakland University William Beaumont School of Medicine and Director of the Heart Rhythm Center at Beaumont Health, Royal Oak, MI, to the ...
-
CardioWise, Inc. Named a Top-Ten Finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub
The University of California San Francisco (UCSF) Health Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. The goal of UCSF Digital Health Awards was to select companies that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital stays, reduced patient and ...
-
Mainstay Medical Announces Limited Commercial Launch of ReActiv8 in the U.S.
Dublin – Ireland, 29 June 2021 – Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the U.S. of ReActiv8, its implantable Restorative Neurostimulation™ system to treat intractable chronic low back pain. The ReActiv8 system will be available in the U.S. through ReActiv8-certified physicians commencing in the summer of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you